The pharmaceutical industry has drawn strong criticism over the past decade for driving up the prices of prescription drugs.
Although Big Pharma executives and supporters argue that these price hikes are necessary in order to sustain research and development (R&D), i.e. innovation to help the development of new medications, not everyone agrees with that rationalization.
According to Rep. Katie Porter (D-CA), the money from increased pricing isn’t being used for the right reasons.
“The facts…
Source link
